Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Nimsky

Showing results (211-220 of 234) with videos related to

Pageof 24
Sort By:
Interventional Neuroradiology : Journal of Peritherapeutic Neuroradiology, Surgical Procedures and Related Neurosciences|November 4, 2025
Initial experience with the antithrombogenic-coated CARESTO stent for venous sinus stenting for idiopathic intracranial hypertension: A multicenter studyMohammad Almohammad, Gabriel Broocks, Peter B Sporns, et al.
Clinical Neuroradiology|August 7, 2025
Comparison of pEGASUS-HPC and CREDO Heal stent systems deployed via NeuroSpeed percutaneous angioplasty balloon catheter for treatment of acute symptomatic intracranial stenosis and occlusionAbdallah Aburub, Mohammad Almohammad, Ali Khanafer, et al.
Journal of Personalized Medicine|October 25, 2024
Subthalamic Stimulation Improves Short-Term Satisfaction with Life and Treatment in Parkinson's DiseaseAnna Sauerbier, Pia Bachon, Leire Ambrosio, et al.
Neuro-Oncology|August 9, 2023
A disintegrin and metalloproteinase 22 activates integrin β1 through its disintegrin domain to promote the progression of pituitary adenomaBiao Xing, Zhuowei Lei, Zihan Wang, et al.
Frontiers in Oncology|April 4, 2022
The Metalloprotease-Disintegrin ADAM8 Alters the Tumor Suppressor miR-181a-5p Expression Profile in Glioblastoma Thereby Contributing to Its AggressivenessAgnes Schäfer, Lara Evers, Lara Meier, et al.
Seizure|February 9, 2020
Predicting outcome of epilepsy surgery in clinical practice: Prediction models vs. clinical acumenAnne Katharina Fassin, Susanne Knake, Adam Strzelczyk, et al.
Cellular Oncology (Dordrecht, Netherlands)|October 16, 2024
The long non-coding RNA NEAT1 contributes to aberrant STAT3 signaling in pancreatic cancer and is regulated by a metalloprotease-disintegrin ADAM8/miR-181a-5p axisYutong Gao, Kimia Zandieh, Kai Zhao, et al.
EMBO Molecular Medicine|September 7, 2022
Proteolytically generated soluble Tweak Receptor Fn14 is a blood biomarker for γ-secretase activityGökhan Güner, Marlene Aßfalg, Kai Zhao, et al.
Scientific Reports|May 27, 2021
Wada test results contribute to the prediction of change in verbal learning and verbal memory function after temporal lobe epilepsy surgeryNadine Conradi, Friederike Rosenberg, Susanne Knake, et al.
Journal of Parkinson'S Disease|November 1, 2021
The New Satisfaction with Life and Treatment Scale (SLTS-7) in Patients with Parkinson's DiseaseAnna Sauerbier, Pia Bachon, Leire Ambrosio, et al.
Pageof 24

Showing results (211-220 of 234) with videos related to

Sort By:
Pageof 24
Interventional Neuroradiology : Journal of Peritherapeutic Neuroradiology, Surgical Procedures and Related Neurosciences|November 4, 2025
Initial experience with the antithrombogenic-coated CARESTO stent for venous sinus stenting for idiopathic intracranial hypertension: A multicenter studyMohammad Almohammad, Gabriel Broocks, Peter B Sporns, et al.
Clinical Neuroradiology|August 7, 2025
Comparison of pEGASUS-HPC and CREDO Heal stent systems deployed via NeuroSpeed percutaneous angioplasty balloon catheter for treatment of acute symptomatic intracranial stenosis and occlusionAbdallah Aburub, Mohammad Almohammad, Ali Khanafer, et al.
Journal of Personalized Medicine|October 25, 2024
Subthalamic Stimulation Improves Short-Term Satisfaction with Life and Treatment in Parkinson's DiseaseAnna Sauerbier, Pia Bachon, Leire Ambrosio, et al.
Neuro-Oncology|August 9, 2023
A disintegrin and metalloproteinase 22 activates integrin β1 through its disintegrin domain to promote the progression of pituitary adenomaBiao Xing, Zhuowei Lei, Zihan Wang, et al.
Frontiers in Oncology|April 4, 2022
The Metalloprotease-Disintegrin ADAM8 Alters the Tumor Suppressor miR-181a-5p Expression Profile in Glioblastoma Thereby Contributing to Its AggressivenessAgnes Schäfer, Lara Evers, Lara Meier, et al.
Seizure|February 9, 2020
Predicting outcome of epilepsy surgery in clinical practice: Prediction models vs. clinical acumenAnne Katharina Fassin, Susanne Knake, Adam Strzelczyk, et al.
Cellular Oncology (Dordrecht, Netherlands)|October 16, 2024
The long non-coding RNA NEAT1 contributes to aberrant STAT3 signaling in pancreatic cancer and is regulated by a metalloprotease-disintegrin ADAM8/miR-181a-5p axisYutong Gao, Kimia Zandieh, Kai Zhao, et al.
EMBO Molecular Medicine|September 7, 2022
Proteolytically generated soluble Tweak Receptor Fn14 is a blood biomarker for γ-secretase activityGökhan Güner, Marlene Aßfalg, Kai Zhao, et al.
Scientific Reports|May 27, 2021
Wada test results contribute to the prediction of change in verbal learning and verbal memory function after temporal lobe epilepsy surgeryNadine Conradi, Friederike Rosenberg, Susanne Knake, et al.
Journal of Parkinson'S Disease|November 1, 2021
The New Satisfaction with Life and Treatment Scale (SLTS-7) in Patients with Parkinson's DiseaseAnna Sauerbier, Pia Bachon, Leire Ambrosio, et al.
Pageof 24